mycosis fungoides

August clinical considerations for NPs and PAsIn this month’s Clinical Considerations, we learn from a new study that laser treatment following isotretinoin therapy can possibly be initiated sooner than we thought; researchers have shown microwave technology may reduce underarm odor, and glean guidance for diagnosing mycosis fungoides.
Managing mycosis fungoidesAlthough there is no cure for this rare type of lymphoma, several different therapies are currently being used that can lead to long-term disease remission, significantly increasing the quality of life of patients.
May Clinical Considerations for NPs, PAsThis month, we take a look at a treatment approach to hidradenitis suppurativa, the impact of atopic dermatitis on pediatric patients and a way to prevent mycosis fungoides progression.
ECP may prevent mycosis fungoides progressionExtracorporeal photopheresis is underused for early-stage mycosis fungoides. ECP is capable of correcting the cytokine imbalance seen in patients with MF and results in an increase of Th1 cytokines. Clinicians should consider more frequent use in select patients
New medical therapies result in symptoms of various skin conditionsDermatologists should learn to recognize some rare and common skin conditions that may result from emerging medical therapies.
Valchlor gel for mycosis fungoides launches in U.S.A topical gel, Valchlor (mechlorethamine, Actelion), is now available in the United States for patients with stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma.